Combination therapy for treatment of depression
CA 2332253 A1 · Owner: Michelson, David · Inventors: Tollefson, Gary Dennis; Michelson, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for treating a patient suffering from depression, comprising administering to said patient an effective amount of a first component which is a 5-HT3 receptor antagonist in combination with an , effective amount of a second component which is a serotonin reuptake inhibitor wherein improvement in sexual dysfunction and/or reduction in gastrointestinal side effects is recognized.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.